CA2399566A1 - Peptides et polypeptides de par4 - Google Patents
Peptides et polypeptides de par4 Download PDFInfo
- Publication number
- CA2399566A1 CA2399566A1 CA002399566A CA2399566A CA2399566A1 CA 2399566 A1 CA2399566 A1 CA 2399566A1 CA 002399566 A CA002399566 A CA 002399566A CA 2399566 A CA2399566 A CA 2399566A CA 2399566 A1 CA2399566 A1 CA 2399566A1
- Authority
- CA
- Canada
- Prior art keywords
- gly
- par4
- pro
- peptide
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Des membres de la famille du récepteur activé par protéase (PAR) induisent une signalisation cellulaire dans la réponse à des protéases. Ces récepteurs sont caractérisés par un ligand peptidique attaché au niveau de la terminaison amino-extracellulaire généré par une protéolyse mineure. Une analyse de structure-activité a révélé que des peptides et des polypeptides peuvent être conçus pour activer le PAR4 humain.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50064600A | 2000-02-09 | 2000-02-09 | |
US09/500,646 | 2000-02-09 | ||
PCT/US2001/003807 WO2001058930A1 (fr) | 2000-02-09 | 2001-02-06 | Peptides et polypeptides de par4 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2399566A1 true CA2399566A1 (fr) | 2001-08-16 |
Family
ID=23990336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002399566A Abandoned CA2399566A1 (fr) | 2000-02-09 | 2001-02-06 | Peptides et polypeptides de par4 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1254160A1 (fr) |
AU (1) | AU2001233333A1 (fr) |
CA (1) | CA2399566A1 (fr) |
WO (1) | WO2001058930A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004080372A2 (fr) * | 2003-03-11 | 2004-09-23 | Bayer Healthcare Ag | Diagnostic et traitement de maladies associees au recepteur 4 active par la proteinase et couple aux proteines g (par 4) |
EP2841448A1 (fr) * | 2012-04-26 | 2015-03-04 | Bristol-Myers Squibb Company | Peptides agonistes de par4 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010041418A (ko) * | 1998-02-27 | 2001-05-15 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 프로테아제-활성화되는 수용체 4 및 그것의 사용 |
US6111075A (en) * | 1998-04-01 | 2000-08-29 | Zymogenetics, Inc. | Protese-activated receptor PAR4 (ZCHEMR2) |
-
2001
- 2001-02-06 CA CA002399566A patent/CA2399566A1/fr not_active Abandoned
- 2001-02-06 AU AU2001233333A patent/AU2001233333A1/en not_active Abandoned
- 2001-02-06 WO PCT/US2001/003807 patent/WO2001058930A1/fr not_active Application Discontinuation
- 2001-02-06 EP EP01905455A patent/EP1254160A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1254160A1 (fr) | 2002-11-06 |
WO2001058930A1 (fr) | 2001-08-16 |
AU2001233333A1 (en) | 2001-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050267035A1 (en) | Peptide and polypeptide inhibitors of complement C1s | |
US7855269B2 (en) | Method for treating inflammation | |
JP4009535B2 (ja) | 可溶性ヘテロダイマーサイトカイン受容体 | |
CA2378519C (fr) | Recepteur de cytokine humaine | |
US7084253B2 (en) | Protease-activated receptor PAR4 (ZCHEMR2) | |
US20020137684A1 (en) | Ligand for enhancing oral and CNS delivery of biological agents | |
CA2303421C (fr) | Defensines-beta | |
CA2399566A1 (fr) | Peptides et polypeptides de par4 | |
CA2427824A1 (fr) | Recepteur cytokinique humain | |
CA2372805A1 (fr) | Variantes de l'autotaxine et leurs utilisations dans le traitement des troubles du metabolisme | |
WO2021142573A1 (fr) | Protéine de fusion, son procédé de préparation et son utilisation | |
EP2578603A1 (fr) | Antagoniste du facteur d'activation des lymphocytes b et son procédé de préparation et son utilisation | |
KR101651330B1 (ko) | 세포투과성이 우수한 tat-a20 융합단백질의 제조방법 및 이의 용도 | |
CA2408387A1 (fr) | Ligand pour ameliorer l'administration d'agents biologiques par voie orale et via le systeme nerveux central | |
WO2004069857A2 (fr) | Peptides, compositions et utilisations associees | |
US7122342B1 (en) | Protease-activated receptor PAR4 (ZCHEMR2) | |
US20020098497A1 (en) | Use of human phermone polypeptides | |
CN113272019A (zh) | 肝细胞生长因子或其活性片段的聚乙二醇修饰体 | |
US20030092117A1 (en) | Zalpha13: a human secreted protein | |
EP1171600A2 (fr) | Zalpha13: proteine humaine secretee | |
CA2374520A1 (fr) | Proteine 32 alpha helicoidale secretee |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |